Reports
Sale
Asia Pacific In-Vitro Diagnostics Market Size, Growth: By Product and Service: Reagents and Kits, Instruments, Software and Services; By Technology: Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Haematology, Others; By Application; By End Use; Regional Analysis; Competitive Landscape; 2024-2032
Asia Pacific In-vitro Diagnostics Market Outlook
The Asia Pacific in-vitro diagnostics market is expected to grow at a CAGR of 5.2% during the period 2024-2032. In-vitro diagnostics can help identify early warning signs and individual risk factors, generating new openings for prevention and early intervention. Some in-vitro diagnostics range beyond the laboratory, hospital or doctor’s office, enabling patients with chronic illnesses to self-monitor and manage their own conditions. Several leading companies offer in-vitro diagnostic (IVD) solutions that deliver rapid, sensitive results while minimizing cost and complexity. Modern in-vitro diagnostics (IVDs) enable better diagnosis for prevention and management of infectious and chronic diseases. These factors are expected to drive market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Likely to be Driven by Demand for Quality Medical Care and Improving Healthcare Infrastructure
Leading in-vitro diagnostics companies seek growth helpful to business plans; regions such as Asia Pacific offer significant market potential. In developing countries, rising levels of income and standards of living are expected to stimulate a new, health-conscious populace seeking quality medical care. Expanding healthcare infrastructure and improved quality of healthcare in countries like India are likely to be driving factors of the Asia Pacific in-vitro diagnostics market. Major companies like Fujifilm offer solutions based on the company’s dry chemistry technology; such solutions help medical practitioners who need immediate and dependable results for early patient treatment and care. The company offers high quality diagnostic reagents and tests. Solutions include:
Beta-Glucan Test - The Toxinometer MT-6500 based β-Glucan Test is an in vitro diagnostic test for the quantitative determination of (1→3)-β-D-glucan in serum or plasma.
µTASWako™ AFP-L3 Test - An in vitro diagnostic blood test for the risk assessment of developing Hepatocellular Carcinoma (HCC).
Autokit CH50 Assay - An in vitro diagnostic (IVD) test for the quantitative determination of total complement activity in human serum.
Total Bilirubin L-Type Assay - An in vitro diagnostic (IVD) test for the quantitative determination of Total Bilirubin (T-BIL) in serum.
In 2020, Sysmex Corporation reached an agreement to invest in Astrego Diagnostics AB to help commercialize a rapid drug susceptibility test1 that Astrego was developing for urinary tract infections.
In 2019, Sysmex Asia Pacific Pte Ltd announced that the Company had begun providing direct sales and support in India for Haematology Business. With over 1.3 billion people, India is the world’s second most populous nation, after China, and the nation’s real GDP continues to grow significantly. In addition to robust economic advancement, India is expanding its healthcare infrastructure and improving its quality of healthcare. Sysmex valued India’s market for in vitro diagnostics at around US$800 million. Moreover, the Company expected this market to grow at a rapid annual pace of around 12-16%, as India’s healthcare infrastructure expanded and its quality of healthcare improved.
In 2023, Fujifilm India Pvt Ltd. unveiled a new range of products at the 74th National Annual Conference of IRIA 2023. The latest portfolio included a range of products offering complete and integrated solutions for diagnostic purposes, including CT, MRI, X-ray, AI, PACS, endoscopy and ultrasound systems through the Scenaria View, Supria series, The Echelon Smart and Arietta series. Offering a diverse portfolio, the new range would include solutions pertaining to CT, MRI, Digital Radiography, AI, PACS, endoscopy, IVD and ultrasound systems.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Segmentation
By product and service, the Asia Pacific in-vitro diagnostics market is segmented into:
- Reagents and Kits
- Instruments
- Software and Services
By technology, the market is classified into:
- Immunoassay/Immunochemistry
- Clinical Chemistry
- Molecular Diagnostics
- Haematology
- Microbiology
- Blood Glucose Self-Monitoring
- Coagulation and Haemostasis
- Urinalysis
- Others
By application, the market is divided into:
- Infectious Diseases
- Diabetes
- Cardiology
- Oncology
- Autoimmune Diseases
- Nephrology
- Others
By end use, the market is segmented into:
- Hospitals
- Laboratories
- Homecare
- Others
By country, the market is classified into:
- China
- Japan
- India
- ASEAN
- Australia
- Others
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Industry Players in the Market
The report presents a detailed analysis of the following key players in the Asia Pacific in-vitro diagnostics market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Sysmex Corporation
- Medical & Biological Laboratories Co., Ltd.
- Voxtur Bio Ltd.
- Immulab
- FUJIFILM Corporation
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product and Service |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Asia Pacific
7 Opportunities and Challenges in the Market
8 Asia Pacific In-Vitro Diagnostics Market Analysis
8.1 Key Industry Highlights
8.2 Asia Pacific In-Vitro Diagnostics Historical Market (2018-2023)
8.3 Asia Pacific In-Vitro Diagnostics Market Forecast (2024-2032)
8.4 Asia Pacific In-Vitro Diagnostics Market by Product and Service
8.4.1 Reagents and Kits
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 Instruments
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Software and Services
8.4.3.2 Historical Trend (2018-2023)
8.4.3.3 Forecast Trend (2024-2032)
8.5 Asia Pacific In-Vitro Diagnostics Market by Technology
8.5.1 Immunoassay/Immunochemistry
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Clinical Chemistry
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Molecular Diagnostics
8.5.3.2 Historical Trend (2018-2023)
8.5.3.3 Forecast Trend (2024-2032)
8.5.4 Haematology
8.5.4.2 Historical Trend (2018-2023)
8.5.4.3 Forecast Trend (2024-2032)
8.5.5 Microbiology
8.5.5.2 Historical Trend (2018-2023)
8.5.5.3 Forecast Trend (2024-2032)
8.5.6 Blood Glucose Self-Monitoring
8.5.6.2 Historical Trend (2018-2023)
8.5.6.3 Forecast Trend (2024-2032)
8.5.7 Coagulation and Haemostasis
8.5.7.2 Historical Trend (2018-2023)
8.5.7.3 Forecast Trend (2024-2032)
8.5.8 Urinalysis
8.5.8.2 Historical Trend (2018-2023)
8.5.8.3 Forecast Trend (2024-2032)
8.5.9 Others
8.6 Asia Pacific In-Vitro Diagnostics Market by Application
8.6.1 Infectious Diseases
8.6.1.2 Historical Trend (2018-2023)
8.6.1.3 Forecast Trend (2024-2032)
8.6.2 Diabetes
8.6.2.2 Historical Trend (2018-2023)
8.6.2.3 Forecast Trend (2024-2032)
8.6.3 Cardiology
8.6.3.2 Historical Trend (2018-2023)
8.6.3.3 Forecast Trend (2024-2032)
8.6.4 Oncology
8.6.4.2 Historical Trend (2018-2023)
8.6.4.3 Forecast Trend (2024-2032)
8.6.5 Autoimmune Diseases
8.6.5.2 Historical Trend (2018-2023)
8.6.5.3 Forecast Trend (2024-2032)
8.6.6 Nephrology
8.6.6.2 Historical Trend (2018-2023)
8.6.6.3 Forecast Trend (2024-2032)
8.6.7 Others
8.7 Asia Pacific In-Vitro Diagnostics Market by End Use
8.7.1 Hospitals
8.7.1.2 Historical Trend (2018-2023)
8.7.1.3 Forecast Trend (2024-2032)
8.7.2 Laboratories
8.7.2.2 Historical Trend (2018-2023)
8.7.2.3 Forecast Trend (2024-2032)
8.7.3 Homecare
8.7.3.2 Historical Trend (2018-2023)
8.7.3.3 Forecast Trend (2024-2032)
8.7.4 Others
8.8 Asia Pacific In-Vitro Diagnostics Market by Country
8.8.1 China
8.8.2 Japan
8.8.3 India
8.8.4 ASEAN
8.8.5 Australia
8.8.6 Others
9 Regional Analysis
9.1 China
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Japan
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.3 India
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.4 ASEAN
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
9.5 Australia
9.5.1 Historical Trend (2018-2023)
9.5.2 Forecast Trend (2024-2032)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Sysmex Corporation
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Medical & Biological Laboratories Co., Ltd.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Voxtur Bio Ltd.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Immulab
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 FUJIFILM Corporation
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Asia Pacific In-Vitro Diagnostics Market: Key Industry Highlights, 2018 and 2032
2. Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by Product and Services (USD Million), 2018-2023
3. Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by Product and Services (USD Million), 2024-2032
4. Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by Technology (USD Million), 2018-2023
5. Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by Technology (USD Million), 2024-2032
6. Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by Application (USD Million), 2018-2023
7. Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by Application (USD Million), 2024-2032
8. Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by End Use (USD Million), 2018-2023
9. Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by End Use (USD Million), 2024-2032
10. Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by Country (USD Million), 2018-2023
11. Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Asia Pacific In-Vitro Diagnostics Market Structure.
Key Questions Answered in the Report
The market is projected to grow at a CAGR of 5.2% between 2024 and 2032.
The major drivers of the Asia Pacific in-vitro diagnostics market include the rising levels of income, rising standards of living, development of automated IVD systems for laboratories and hospitals, increasing requirement for genetic testing for personalised health care, and supportive government policies.
Expanding healthcare infrastructure and rising number of IVD (in vitro diagnostics) products being launched by key players are the key industry trends propelling the market's growth.
The major regions in the industry are China, Japan, India, ASEAN, and Australia, among others.
The various products and services in the market are reagents and kits, instruments, software and services.
Based on technology, the market is segmented into immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, haematology, microbiology, blood glucose self-monitoring, coagulation and haemostasis, and urinalysis, among others.
The major applications of the market are infectious diseases, diabetes, cardiology, oncology, autoimmune diseases, and nephrology, among others.
The end-uses of the market are hospitals, laboratories, and homecare, among others.
The major players in the industry are Sysmex Corporation, Medical & Biological Laboratories Co., Ltd., Voxtur Bio Ltd., Immulab, and FUJIFILM Corporation, among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER